Polyclonal Rabbit anti‑Human KIR2DS4 Antibody (Biotin, aa22‑302, WB) LS‑C686053
Polyclonal Rabbit anti‑Human KIR2DS4 Antibody (Biotin, aa22‑302, WB) LS‑C686053
Note: This antibody replaces LS-C297212
Antibody:
KIR2DS4 Rabbit anti-Human Polyclonal (aa22-302) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
KIR2DS4 Rabbit anti-Human Polyclonal (aa22-302) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
KIR2DS4 antibody LS-C686053 is a biotin-conjugated rabbit polyclonal antibody to human KIR2DS4 (aa22-302). Validated for WB.
Target
Human KIR2DS4
Synonyms
KIR2DS4 | CD158I | KIR antigen 2DS4 | MHC class I NK cell receptor | NKAT8 | KKA3 | NKAT-8 | CD158i antigen | Cl-39 | KIR1D | KIR412 | p58 NK receptor CL-39/CL-17
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant KIR2DS4 (Gln22-Ser302) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against KIR2DS4.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot, Flow Cytometry
Species:
Human
Applications:
Flow Cytometry
Source:
E. coli
Tag:
None
Reactivity:
Human
Range:
3.12-200 ng/ml
Reactivity:
Pig
Range:
0.78-50 ng/ml
Reactivity:
Mouse
Range:
0.16-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/24/2024